Toll like receptor signaling pathway as a potential therapeutic target in colorectal cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Toll like receptor signaling pathway as a potential therapeutic target in colorectal cancer
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR PHYSIOLOGY
Volume 233, Issue 8, Pages 5613-5622
Publisher
Wiley
Online
2017-11-18
DOI
10.1002/jcp.26273
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Predictive value of TLR7 polymorphism for cetuximab-based chemotherapy in patients with metastatic colorectal cancer
- (2017) Satoshi Okazaki et al. INTERNATIONAL JOURNAL OF CANCER
- Therapeutic Potential of Curcumin in Treatment of Pancreatic Cancer: Current Status and Future Perspectives
- (2017) Mina Hosseini et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- The therapeutic potential of targeting the BRAF mutation in patients with colorectal cancer
- (2017) Afsane Bahrami et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Genetic variants as potential predictive biomarkers in advanced colorectal cancer patients treated with oxaliplatin-based chemotherapy
- (2017) Afsane Bahrami et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Targeting RAS signaling pathway as a potential therapeutic target in the treatment of colorectal cancer
- (2017) Afsane Bahrami et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Role of Wnt/β-catenin signaling regulatory microRNAs in the pathogenesis of colorectal cancer
- (2017) Farzad Rahmani et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Two-step enhanced cancer immunotherapy with engineeredSalmonella typhimuriumsecreting heterologous flagellin
- (2017) Jin Hai Zheng et al. Science Translational Medicine
- Divergent expression of bacterial wall sensing Toll-like receptors 2 and 4 in colorectal cancer
- (2017) Karoliina Paarnio et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Toll-like receptor 3 as an immunotherapeutic target for KRAS mutated colorectal cancer
- (2017) Radhashree Maitra et al. Oncotarget
- Randomized phase III trial of paclitaxel/carboplatin with or without PF-3512676 as first line treatment of advanced non-small cell lung cancer (NSCLC)
- (2017) V. Hirsh et al. JOURNAL OF CLINICAL ONCOLOGY
- Toll-like receptor signaling in colorectal cancer: Carcinogenesis to cancer therapy
- (2017) Ting-Ting Li et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Structural Change in Microbiota by a Probiotic Cocktail Enhances the Gut Barrier and Reduces Cancer via TLR2 Signaling in a Rat Model of Colon Cancer
- (2016) Eugene Dogkotenge Kuugbee et al. DIGESTIVE DISEASES AND SCIENCES
- Application potential of toll-like receptors in cancer immunotherapy
- (2016) Ming Shi et al. MEDICINE
- Intratumoral injection of a CpG oligonucleotide reverts resistance to PD-1 blockade by expanding multifunctional CD8+T cells
- (2016) Shu Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Integration of Innate Immune Signaling
- (2016) Christoph A. Thaiss et al. TRENDS IN IMMUNOLOGY
- Lipopolysaccharide-induced α-catenin downregulation enhances the motility of human colorectal cancer cells in an NF-κB signaling-dependent manner
- (2016) Guoping Cheng et al. OncoTargets and Therapy
- Co-operation of -galactosylceramide-loaded tumour cells and TLR9 agonists induce potent anti-tumour responses in a murine colon cancer model
- (2015) T. Dong et al. BIOCHEMICAL JOURNAL
- Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumours
- (2015) Martin R. Weihrauch et al. EUROPEAN JOURNAL OF CANCER
- Inhibition of indoleamine 2,3-dioxygenase activity enhances the anti-tumour effects of a Toll-like receptor 7 agonist in an established cancer model
- (2015) Hiroyasu Ito et al. IMMUNOLOGY
- Early detection of colorectal cancer: from conventional methods to novel biomarkers
- (2015) Nasimeh Vatandoost et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Targeting of MyD88 Homodimerization by Novel Synthetic Inhibitor TJ-M2010-5 in Preventing Colitis-Associated Colorectal Cancer
- (2015) Lin Xie et al. JNCI-Journal of the National Cancer Institute
- Toll-like receptor signalling through macromolecular protein complexes
- (2015) Clare E. Bryant et al. MOLECULAR IMMUNOLOGY
- Targeting of MyD88 Homodimerization by Novel Synthetic Inhibitor TJ-M2010-5 in Preventing Colitis-Associated Colorectal Cancer
- (2015) Lin Xie et al. JNCI-Journal of the National Cancer Institute
- Cancer treatment and survivorship statistics, 2014
- (2014) Carol E. DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Modulation of Signaling Enhances the Efficacy of the Combination of Satraplatin and Erlotinib
- (2014) Abolfazl Avan et al. CURRENT DRUG TARGETS
- A novel systemically administered toll-like receptor 7 agonist potentiates the effect of ionizing radiation in murine solid tumor models
- (2014) Amy L. Adlard et al. INTERNATIONAL JOURNAL OF CANCER
- Maintenance treatment with the immunomodulator MGN1703, a Toll-like receptor 9 (TLR9) agonist, in patients with metastatic colorectal carcinoma and disease control after chemotherapy: a randomised, double-blind, placebo-controlled trial
- (2014) Hans-Joachim Schmoll et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Microbiota and radiation-induced bowel toxicity: lessons from inflammatory bowel disease for the radiation oncologist
- (2014) Miguel R Ferreira et al. LANCET ONCOLOGY
- A novel TLR-9 agonist C792 inhibits plasmacytoid dendritic cell-induced myeloma cell growth and enhance cytotoxicity of bortezomib
- (2014) A Ray et al. LEUKEMIA
- Graphene Oxide Triggers Toll-Like Receptors/Autophagy Responses In Vitro and Inhibits Tumor Growth In Vivo
- (2014) Guan-Yu Chen et al. Advanced Healthcare Materials
- Toll-Like Receptor Signaling Pathways
- (2014) Takumi Kawasaki et al. Frontiers in Immunology
- Toll-Like Receptors and Prostate Cancer
- (2014) Shu Zhao et al. Frontiers in Immunology
- Phase I study of OM-174, a lipid A analogue, with assessment of immunological response, in patients with refractory solid tumors
- (2013) Nicolas Isambert et al. BMC CANCER
- TLR4 is essential for dendritic cell activation and anti-tumor T-cell response enhancement by DAMPs released from chemically stressed cancer cells
- (2013) Hongliang Fang et al. Cellular & Molecular Immunology
- Toll-like Receptor-4 Expression by Stromal Fibroblasts Is Associated With Poor Prognosis in Colorectal Cancer
- (2013) Noemí Eiró et al. JOURNAL OF IMMUNOTHERAPY
- TLR agonists: our best frenemy in cancer immunotherapy
- (2013) Sabina Kaczanowska et al. JOURNAL OF LEUKOCYTE BIOLOGY
- TLR2 and TLR4 in the Brain Injury Caused by Cerebral Ischemia and Reperfusion
- (2013) Ying Wang et al. MEDIATORS OF INFLAMMATION
- Peripheral CD45RO, PD-1, and TLR4 expression in metastatic colorectal cancer patients treated with bevacizumab, fluorouracil, and irinotecan (FOLFIRI-B)
- (2013) Vincenzo Formica et al. MEDICAL ONCOLOGY
- Role of the Toll Like Receptor (TLR) Radical Cycle in Chronic Inflammation: Possible Treatments Targeting the TLR4 Pathway
- (2013) Kurt Lucas et al. MOLECULAR NEUROBIOLOGY
- The Yin and Yang of Toll-like receptors in cancer
- (2013) J-P Pradere et al. ONCOGENE
- Central role of liver in anticancer and radioprotective activities of Toll-like receptor 5 agonist
- (2013) L. G. Burdelya et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- dsRNA induces apoptosis through an atypical death complex associating TLR3 to caspase-8
- (2012) Y Estornes et al. CELL DEATH AND DIFFERENTIATION
- Molecular Pathways: Toll-like Receptors in the Tumor Microenvironment--Poor Prognosis or New Therapeutic Opportunity
- (2012) L. A. Ridnour et al. CLINICAL CANCER RESEARCH
- New developments in Toll-like receptor targeted therapeutics
- (2012) Dympna J Connolly et al. CURRENT OPINION IN PHARMACOLOGY
- Functional polymorphisms of Toll-like receptors 2 and 4 alter the risk for colorectal carcinoma in Europeans
- (2012) Pedro Pimentel-Nunes et al. DIGESTIVE AND LIVER DISEASE
- Study of the Expression of Toll-Like Receptors in Different Histological Types of Colorectal Polyps and Their Relationship with Colorectal Cancer
- (2012) Noemí Eiró et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Modulating immunity as a therapy for bacterial infections
- (2012) Robert E. W. Hancock et al. NATURE REVIEWS MICROBIOLOGY
- TLR-4 Signalling Accelerates Colon Cancer Cell Adhesion via NF-κB Mediated Transcriptional Up-Regulation of Nox-1
- (2012) D. Peter O'Leary et al. PLoS One
- Toll-like receptor 3 agonist complexed with cationic liposome augments vaccine-elicited antitumor immunity by enhancing TLR3–IRF3 signaling and type I interferons in dendritic cells
- (2012) Ce Wang et al. VACCINE
- Trial Watch
- (2012) Lorenzo Galluzzi et al. OncoImmunology
- Targeting the Immune System to Fight Cancer Using Chemical Receptor Homing Vectors Carrying Polyinosine/Cytosine (PolyIC)
- (2012) Alexander Levitzki Frontiers in Oncology
- Tissue expression of Toll-like receptors 2 and 4 in sporadic human colorectal cancer
- (2011) Yasuhiro Nihon-Yanagi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Intratumoral Administration of TLR4 Agonist Absorbed into a Cellular Vector Improves Antitumor Responses
- (2011) M. B. Davis et al. CLINICAL CANCER RESEARCH
- Toll-like receptor genes and their association with colon and rectal cancer development and prognosis
- (2011) Martha L. Slattery et al. INTERNATIONAL JOURNAL OF CANCER
- CpG ODN, Toll Like Receptor (TLR)-9 Agonist, Inhibits Metastatic Colon Adenocarcinoma in a Murine Hepatic Tumor Model
- (2011) Ik Yong Kim et al. JOURNAL OF SURGICAL RESEARCH
- The Structural Biology of Toll-like Receptors
- (2011) Istvan Botos et al. STRUCTURE
- Expression and Functional Research of TLR4 in Human Colon Carcinoma
- (2010) Xiao-Yan Tang et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Bacillus Calmette-Guerin cell wall cytoskeleton enhances colon cancer radiosensitivity through autophagy
- (2010) Jae-Min Yuk et al. Autophagy
- High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer
- (2010) E L Wang et al. BRITISH JOURNAL OF CANCER
- Potentiation of the antitumor effects of imidazoquinoline immune response modifiers by cyclophosphamide
- (2010) Calin D. Dumitru et al. CANCER BIOLOGY & THERAPY
- TLR3 induction by anticancer drugs potentiates poly I:C-induced tumor cell apoptosis
- (2010) Manabu Taura et al. CANCER SCIENCE
- Control of infection by pyroptosis and autophagy: role of TLR and NLR
- (2010) Karina R. Bortoluci et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Toll-like receptors in inflammatory bowel diseases: A decade later
- (2010) Elke Cario INFLAMMATORY BOWEL DISEASES
- MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18
- (2010) Rosalba Salcedo et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The tumor microenvironment of colorectal cancer: stromal TLR-4 expression as a potential prognostic marker
- (2010) Rosaria Cammarota et al. Journal of Translational Medicine
- Toll-Like Receptor 2 Signaling Protects Mice from Tumor Development in a Mouse Model of Colitis-Induced Cancer
- (2010) Emily L. Lowe et al. PLoS One
- TIR-containing adaptors in Toll-like receptor signalling
- (2009) Kristie A. Jenkins et al. CYTOKINE
- Toll-like receptors and the tendency of normal mucous membrane to transform to polyp or colorectal cancer
- (2009) I. Niedzielska et al. INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
- Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
- (2009) J Paavonen et al. LANCET
- How Location Governs Toll-Like Receptor Signaling
- (2009) Akanksha Chaturvedi et al. TRAFFIC
- Ampligen: A potential toll-like 3 receptor adjuvant for immunotherapy of cancer
- (2009) B. Jasani et al. VACCINE
- An Exploratory Study of Systemic Administration of the Toll-like Receptor-7 Agonist 852A in Patients with Refractory Metastatic Melanoma
- (2008) R. Dummer et al. CLINICAL CANCER RESEARCH
- Toll-Like Receptor 5 Engagement Modulates Tumor Development and Growth in a Mouse Xenograft Model of Human Colon Cancer
- (2008) Sang Hoon Rhee et al. GASTROENTEROLOGY
- Structural Basis of Toll-Like Receptor 3 Signaling with Double-Stranded RNA
- (2008) L. Liu et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now